The Use of Cefepime for Treating AmpC β-Lactamase―Producing Enterobacteriaceae
The Use of Cefepime for Treating AmpC β-Lactamase―Producing Enterobacteriaceae
About this item
Full title
Author / Creator
Publisher
Oxford: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: Oxford University Press
Subjects
More information
Scope and Contents
Contents
AmpC β-lactamase-producing organisms are associated with significant morbidity and mortality. Induction of resistance to third-generation cephalosporins after exposure to these agents complicates treatment options and carbapenems are considered optimal therapy. The role of cefepime, however, remains unclear. Our objective was to compare clinical ou...
Alternative Titles
Full title
The Use of Cefepime for Treating AmpC β-Lactamase―Producing Enterobacteriaceae
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1427746129
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1427746129
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1093/cid/cit395
